Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Cash-to-Debt : 18.05 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Beijing Tong Ren Tang Chinese Medicine Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Beijing Tong Ren Tang Chinese Medicine Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 18.05.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Beijing Tong Ren Tang Chinese Medicine Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt or its related term are showing as below:

HKSE:03613' s Cash-to-Debt Range Over the Past 10 Years
Min: 17.42 Med: 940.11 Max: No Debt
Current: 18.05

During the past 13 years, Beijing Tong Ren Tang Chinese Medicine Co's highest Cash to Debt Ratio was No Debt. The lowest was 17.42. And the median was 940.11.

HKSE:03613's Cash-to-Debt is ranked better than
80.99% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs HKSE:03613: 18.05

Beijing Tong Ren Tang Chinese Medicine Co Cash-to-Debt Historical Data

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Beijing Tong Ren Tang Chinese Medicine Co Cash-to-Debt Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

19.71

17.42

17.71

21.77

18.05

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															17.71	21.44	21.77	19.06	18.05

Competitive Comparison of Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt falls into.

Beijing Tong Ren Tang Chinese Medicine Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Beijing Tong Ren Tang Chinese Medicine Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2378.693	/	(56.42	+	75.393)
	=	18.05

Beijing Tong Ren Tang Chinese Medicine Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2378.693	/	(56.42	+	75.393)
	=	18.05

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Beijing Tong Ren Tang Chinese Medicine Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Beijing Tong Ren Tang Chinese Medicine Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Tong Ren Tang Chinese Medicine Co Ltd (HKSE:03613) » Definitions » Cash-to-Debt

Traded in Other Exchanges

TQR:Germany

Address

Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG

Website

https://cm.tongrentang.com

Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products, Mainland China (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Mainland China and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd, and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Headlines

No Headlines